PL3079684T3 - Kompozycje i sposoby do leczenia chorób związanych z układem renina-angiotensyna - Google Patents

Kompozycje i sposoby do leczenia chorób związanych z układem renina-angiotensyna

Info

Publication number
PL3079684T3
PL3079684T3 PL14844969T PL14844969T PL3079684T3 PL 3079684 T3 PL3079684 T3 PL 3079684T3 PL 14844969 T PL14844969 T PL 14844969T PL 14844969 T PL14844969 T PL 14844969T PL 3079684 T3 PL3079684 T3 PL 3079684T3
Authority
PL
Poland
Prior art keywords
renin
angiotensin
compositions
treatment
methods
Prior art date
Application number
PL14844969T
Other languages
English (en)
Inventor
Marko POGLITSCH
Cornelia SCHWAGER
Hans Loibner
Original Assignee
Alterras Therapeutics Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP14150608.9A external-priority patent/EP2893925A1/en
Application filed by Alterras Therapeutics Gmbh filed Critical Alterras Therapeutics Gmbh
Publication of PL3079684T3 publication Critical patent/PL3079684T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/401—Proline; Derivatives thereof, e.g. captopril
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4813—Exopeptidases (3.4.11. to 3.4.19)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL14844969T 2013-12-11 2014-12-11 Kompozycje i sposoby do leczenia chorób związanych z układem renina-angiotensyna PL3079684T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP13196740 2013-12-11
EP14150608.9A EP2893925A1 (en) 2014-01-09 2014-01-09 Compositions and methods for the treatment of diseases related to the renin-angiotensin-system
PCT/EP2014/077452 WO2015086774A1 (en) 2013-12-11 2014-12-11 Compositions and methods for the treatment of diseases related to the renin-angiotensin-system
EP14844969.7A EP3079684B1 (en) 2013-12-11 2014-12-11 Compositions and methods for the treatment of diseases related to the renin-angiotensin-system

Publications (1)

Publication Number Publication Date
PL3079684T3 true PL3079684T3 (pl) 2020-06-01

Family

ID=52672221

Family Applications (1)

Application Number Title Priority Date Filing Date
PL14844969T PL3079684T3 (pl) 2013-12-11 2014-12-11 Kompozycje i sposoby do leczenia chorób związanych z układem renina-angiotensyna

Country Status (5)

Country Link
US (2) US9839668B2 (pl)
EP (2) EP3650020A1 (pl)
ES (1) ES2761562T3 (pl)
PL (1) PL3079684T3 (pl)
WO (1) WO2015086774A1 (pl)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9839668B2 (en) * 2013-12-11 2017-12-12 Attoquant Diagnostics Gmbh Compositions and methods for the treatment of diseases related to the renin-angiotensin-system
CN115177742B (zh) * 2022-05-30 2024-04-19 北京大学深圳医院 一种载药脑靶向外泌体的制备方法及其应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2773712B1 (fr) 1998-01-16 2000-06-02 Inst Nat Sante Rech Med Composition pharmaceutique comprenant au moins un inhibiteur de l'aminopeptidase a
AT506632A1 (de) * 2008-04-09 2009-10-15 Apeiron Biolog Forschungs Und Behandlung von tumorerkrankungen
JP6170143B2 (ja) 2012-06-06 2017-07-26 アトークアント・ダイアグノスティクス・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツングＡｔｔｏｑｕａｎｔ Ｄｉａｇｎｏｓｔｉｃｓ Ｇｍｂｈ 血液試料中のタンパク質分解カスケードのペプチド分解産物の測定方法
US9839668B2 (en) * 2013-12-11 2017-12-12 Attoquant Diagnostics Gmbh Compositions and methods for the treatment of diseases related to the renin-angiotensin-system

Also Published As

Publication number Publication date
WO2015086774A1 (en) 2015-06-18
US20160310562A1 (en) 2016-10-27
EP3079684B1 (en) 2019-11-13
US9839668B2 (en) 2017-12-12
US20180200330A1 (en) 2018-07-19
EP3650020A1 (en) 2020-05-13
ES2761562T3 (es) 2020-05-20
EP3079684A1 (en) 2016-10-19

Similar Documents

Publication Publication Date Title
IL273090B (en) Methods and preparations for the treatment of cancer
EP2958936A4 (en) METHOD AND COMPOSITIONS FOR TREATING CORI DISEASE
HUE065662T2 (hu) Készítmények és eljárások betegségek kezelésére
ZA201601024B (en) Methods and compositions for treating brain diseases
IL241191A0 (en) Local compositions and methods for treating local disorders
GB201320723D0 (en) Composition and methods of treatment
IL241264A0 (en) Compounds and compositions for the treatment of parasitic diseases
SG11201601412XA (en) Compositions and methods for the treatment of presbyopia
EP3049070A4 (en) Compositions and methods for treatment and prophylaxis of gastrointestinal diseases
SG10201709090UA (en) Sobetirome in the treatment of myelination diseases
IL239851A0 (en) Methods and compositions for treating diseases that act to remove myelin
HUE064634T2 (hu) Kardiovaszkuláris betegségek kezelése
IL239921A0 (en) Preparations containing solutions in solid state and their use for the treatment of pain
GB201404403D0 (en) Compositions and methods relating to the treatment of diseases
SG11201605316VA (en) Methods and compositions relating to p62/sqstm1 for the treatment and prevention of inflammation-associated diseases
PL2968478T3 (pl) Kompozycje i sposoby do leczenia karboksyhemoglobinemii
PL2892556T3 (pl) Kompozycje i sposoby odnoszące się do leczenia chorób
ZA201408057B (en) Compositions and methods for the treatment of moderate to severe pain
ZA201509360B (en) Compositions and methods for treatment of stroke
PT2992094T (pt) Composições e métodos para tratamento de diabetes tipo 1
GB201516303D0 (en) Compositions and methods relating to the treatment of diseases
GB201516437D0 (en) Compositions and methods relating to the treatment of disease
AU2013902004A0 (en) Compositions for Therapy and Methods of Treatment
GB201315079D0 (en) Novel compounds useful for the treatment of degenerative and inflammatory diseases
GB201314016D0 (en) Novel compounds useful for the treatment of degenerative and inflammatory diseases